Press release
Comprehensive Arthralgia Market Insights: Forecasting Size, Growth, and Competitive Trends from 2025 to 2034
Arthralgia
The increasing incidence of rheumatoid arthritis is expected to spur the growth of the arthralgia market in the future. Rheumatoid arthritis is a chronic autoimmune disorder primarily affecting the joints, leading to inflammation, pain, and potential joint damage. The increasing cases of rheumatoid arthritis are attributed to factors such as aging populations, genetic predisposition, lifestyle changes, and environmental elements like smoking and pollution. Rheumatoid arthritis (RA) causes arthralgia by inducing chronic joint inflammation, resulting in pain, stiffness, and progressive joint damage. For instance, in February 2024, Arthritis Australia, an Australian nonprofit organization, projected that by 2040, arthritis cases in Australia would increase to 5.39 million from 4.11 million in 2025, with osteoarthritis growing to 3.11 million from 2.35 million, and rheumatoid arthritis reaching 748,721. Therefore, the rising number of rheumatoid arthritis cases is driving the growth of the arthralgia market.
Get Your Arthralgia Market Report Here:
https://www.thebusinessresearchcompany.com/report/arthralgia-global-market-report
What is the projected compound annual growth rate (CAGR) of the arthralgia market from 2025 to 2034, and what factors influence it?
The arthralgia market has experienced strong growth. It is forecasted to expand from $5.20 billion in 2024 to $5.64 billion in 2025, with a CAGR of 8.5%. The past period's growth was influenced by the rising prevalence of autoimmune diseases, increased risk factors such as obesity, a higher incidence of joint disorders, and an overall rise in arthralgia cases.
The arthralgia market size is expected to grow considerably in the next few years, reaching $7.73 billion by 2029 with a CAGR of 8.2%. Factors contributing to this growth include increased awareness of arthralgia, an aging population, improvements in healthcare infrastructure, rising demand for minimally invasive treatments, and a growing prevalence of sports-related injuries. Key trends anticipated include the integration of digital health solutions, the emergence of novel and cell therapies, medical technology advancements, and higher investments in research and development.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21104&type=smp
How are the latest trends influencing the growth of the arthralgia market?
Major companies in the arthralgia market are focusing on developing innovative therapies, such as RMAT-designated gene therapy, to provide long-term pain relief and improve joint function. RMAT (Regenerative Medicine Advanced Therapy) designation by the FDA expedites the development of gene therapies for serious conditions. For example, in March 2024, Pacira BioSciences Inc., a U.S.-based pharmaceutical company, received RMAT designation for its gene therapy candidate PCRX-201 (enekinragene inzadenovec), a treatment for knee osteoarthritis. This therapy uses a helper-dependent adenovirus to produce interleukin-1 receptor antagonists (IL-1Ra), with preliminary results suggesting it may be a disease-modifying treatment for osteoarthritis.
What are the major segments of the arthralgia market and their role in driving growth?
The arthralgia market covered in this report is segmented -
1) By Cause: Osteoarthritis, Rheumatoid Arthritis, Gout, Psoriatic Arthritis, Lupus, Injuries, Infections, Other Causes
2) By Treatment Type: Medications, Therapies, Surgical Interventions, Lifestyle And Home Remedies
3) By Route Of Administration: Oral, Injectable, Topical, Transdermal
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
5) By End User: Hospital, Clinics, Homecare Settings, Rehabilitation Centers
Subsegments:
1) By Osteoarthritis: Knee Osteoarthritis, Hip Osteoarthritis, Hand Osteoarthritis, Spine Osteoarthritis, Shoulder Osteoarthritis
2) By Rheumatoid Arthritis: Seropositive Rheumatoid Arthritis, Seronegative Rheumatoid Arthritis, Juvenile Rheumatoid Arthritis, Early-Onset Rheumatoid Arthritis
3) By Gout: Primary Gout, Secondary Gout, Gouty Arthritis
4) By Psoriatic Arthritis: Symmetric Psoriatic Arthritis, Asymmetric Psoriatic Arthritis, Psoriatic Spondylitis, Distal Interphalangeal Predominant Psoriatic Arthritis
5) By Lupus: Systemic Lupus Erythematosus (SLE), Discoid Lupus Erythematosus, Drug-induced Lupus, Neonatal Lupus
6) By Injuries: Sports-related Injuries, Trauma and Fractures, Sprains and Strains, Tendon or Ligament Damage
7) By Infections: Septic Arthritis, Viral Arthritis, Bacterial Infections, Fungal Infections
8) By Other Causes: Fibromyalgia, Overuse Injuries, Sarcoidosis, Ankylosing Spondylitis, Crystal-induced Arthritis
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21104
Which regions are key players in the growth of the arthralgia market?
North America was the largest region in the arthralgia market in 2024. The regions covered in the arthralgia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Who are the key firms paving the way for growth in the arthralgia market?
Major companies operating in the arthralgia market are Pfizer Inc., Johnson & Johnson Services Inc., AbbVie Inc., Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis AG, GlaxoSmithKline PLC, Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Biogen Inc., UCB S.A., Hikma Pharmaceuticals PLC, Ferring Pharmaceuticals, KD Pharma Group S.A., SI-BONE Inc., Xalud Therapeutics Inc., Incannex Healthcare Limited, Cytonics Corporation, Vitazan Herbs and Vitamins Inc.
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=21104&type=smp
What Is Covered In The Arthralgia Global Market Report?
•Market Size Forecast: Examine the arthralgia market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the arthralgia market for a structured understanding.
•Key Players Overview: Analyze major players in the arthralgia market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the arthralgia market.
•Segment Contributions: Evaluate how different segments drive overall growth in the arthralgia market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the arthralgia market.
•Industry Challenges: Identify potential risks and obstacles affecting the arthralgia market.
•Competitive Landscape: Review strategic developments in the arthralgia market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Comprehensive Arthralgia Market Insights: Forecasting Size, Growth, and Competitive Trends from 2025 to 2034 here
News-ID: 3934411 • Views: …
More Releases from The Business Research Company
Rising Incidence of Dental Disorders Sparks Growth in the Tooth-Filling Material …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Tooth Filling Materials Market Through 2025?
In the past few years, the market size for tooth filling materials has experienced robust growth. Projected to rise from $1.82 billion in 2024 to $1.92 billion in 2025, it's set to journey at a compound…
2025-2034 Stress Tests Equipment Market Outlook: Key Drivers, Emerging Challenge …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Stress Tests Equipment Industry Market Size Be by 2025?
In recent years, the market for stress test equipment has seen robust growth. From a value of $2.99 billion in 2024, it is projected to increase to $3.19 billion in 2025, reflecting a compound annual growth rate…
2025 Positron Emission Tomography (PET) Scanners Industry Trends Report: Long-Te …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Positron Emission Tomography (PET) Scanners Market Size By 2025?
The market size for positron emission tomography (pet) scanners has been witnessing a steady increment in the past years. The market is expected to escalate from $1.51 billion in 2024 to $1.58 billion in 2025, registering…
Strategic Forecast for the Ostomy Devices Industry: Market Outlook 2025-2034
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Ostomy Devices Market Size Growth Forecast: What to Expect by 2025?
In the past few years, the ostomy devices market has been consistently expanding. Projections show an increase from $2.8 billion in 2024 to $2.9 billion in 2025, maintaining a compound annual growth rate (CAGR) of 3.9%. The significant…
More Releases for Arthritis
Rising Arthritis Cases Fueling Market Growth For Rheumatoid Arthritis Drugs: Piv …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Rheumatoid Arthritis Drugs Market Size Growth Forecast: What to Expect by 2025?
In recent years, there has been a slight decline in the rheumatoid arthritis drugs market size. It is projected to rise from "$60.3 billion in 2024 to $60.1 billion in 2025, with a compound annual growth rate…
Infectious Arthritis (Septic Arthritis) Market Detailed Industry Report Analysis …
Introduction
Infectious arthritis, also known as septic arthritis, is a serious joint condition caused by bacterial, viral, or fungal infections that lead to rapid joint destruction if not treated promptly. The disease primarily affects large joints such as the knee and hip but can also impact smaller joints. It is considered a medical emergency requiring rapid diagnosis and treatment with antibiotics or antifungals, often combined with joint drainage or surgical intervention.
The…
Nooro Arthritis Hand Massager Reviews: Is the Nooro Arthritis Hand Massager Wort …
The Nooro Arthritis Hand Massager is a revolutionary device designed to offer relief to individuals suffering from hand pain, particularly those dealing with conditions such as arthritis, carpal tunnel syndrome, and repetitive strain injuries. As hand pain can significantly impact daily activities, from typing to gripping objects, finding an effective, non-invasive solution is crucial. The Nooro Arthritis Hand Massager provides a gentle yet effective remedy by combining advanced heat therapy…
Rheumatoid Arthritis Drug Market Rheumatoid Arthritis Clinical Pipeline Report 2 …
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
Antirheumatoids: Call of Rheumatoid Arthritis
1.1 Prologue towards Rheumatoid Arthritis
1.2 Obtainable Treatment for Rheumatoid Arthritis
Molecular Mechanism of Antirheumatoids
2.1 Purpose of DMARDs in Rheumatoid Arthritis
2.2 Role of Biological Agents in Rheumatoid Arthritis
2.2.1 TNF- Inhibitors
2.2.2 Interleukin -1 and IL-6 Blockers
Classification of Rheumatoid Arthritis Drugs
3.1…
Rheumatoid Arthritis Treatment Market
Rheumatoid arthritis (RA) is the most common autoimmune arthritis affecting more than 1.3 million U.S. citizens (American College of Rheumatology). More surprising is to know that around 75% of this affected population is women. Affecting the joints at any age, rheumatoid arthritis needs to be addressed early to avoid expensive joint replacement surgery. While it can affect any joint, small joints in hand and feet tend to be affected the…
Worldwide Arthritis - EpiCast Report: Rheumatoid Arthritis - Epidemiology Foreca …
"EpiCast Report: Rheumatoid Arthritis - Epidemiology Forecast to 2025" The Report covers current Industries Trends, Worldwide Analysis, Global Forecast, Review, Share, Size, Growth, Effect.
Description-
** Summary
Rheumatoid arthritis (RA) is an autoimmune disease characterized by inflammation of the joints, bone and cartilage erosion, and joint deformity. Additionally, the condition manifests itself in multiple joints in the body. In RA, the bodys immune system attacks the lining of the joints, known as…
